Goldman Sachs downgraded Amdocs Ltd. (NYSE: DOX) from Buy to Neutral and lowers their price target from $32 to $30.
This article: 104 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE